Pdt Partners, LLC Organogenesis Holdings Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $118,870 - $243,420	-37,857 Reduced 31.17%	83,598 $271,000
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $358,979 - $617,232	75,734 Added 165.64%	121,455 $593,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $295,814 - $437,549	45,721 New	45,721 $348,000
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $2.19 Million - $2.75 Million	-160,067 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $2.39 Million - $3.72 Million	160,067 New	160,067 $2.66 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.